Delivery Order SPE2DX22D0010-SPE2D824FLJ77
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- The Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $4,605.69 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product, to be completed by February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.60 Firm Fixed Price Delivery Order contract is for the supply of XTAMPZA ER 13.5 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The award has a ceiling value of $5,229.60 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,122.80, is for the delivery of XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 5, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.68 fixed-price delivery order contract is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,268.31 firm fixed price delivery order is for the supply of the medication XTAMPZA ER 36 MG CAPSULE 100S. Amerisourcebergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,439.20, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $1,122.80 firm-fixed-price contract is for the supply of XTAMPZA ER CAPS 13.5MG, a prescription pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FLJ77Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,158,451 units of the pharmaceutical product XTAMPZA ER CAPS 27MG. The $3,833.76 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to serve as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/3/24 |